Lifestyle Redesign For Schizophrenia

Schizophrenia Clinical Trial

Official title:

The Impact of Lifestyle Redesign Program in Schizophrenia

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT04430868
• Other study ID #: B20190705
• Status: Not yet recruiting
• Phase: N/A
• Start date: July 1, 2020
• Est. completion date: November 30, 2020

Study information

• Verified date: June 2020
• Source: Taoyuan Psychiatric Center, Ministry of Health and Welfare, Executive Yuan, R.O.C. Taiwan
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study aimed to investigate the effects of lifestyle redesign program plus treatment as usual versus treatment as usual on cognition, psychiatric symptoms, quality of life, and occupational engagement for schizophrenia.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 30
• Est. completion date: November 30, 2020
• Est. primary completion date: November 30, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 20 Years to 65 Years

Eligibility

Inclusion Criteria:

• diagnosis of schizophrenia, based on the ICD-10 diagnostic criteria for research (World Health Organization, 1992)

• age from 20 to 65

• attending day care center regularly for at least 1 month and taking stable dose of medication

Exclusion Criteria:

• comorbid other mental disorder (e.g. depression, anxiety, ADHD...etc.)

• comorbid mental retardation

• lacking the reading and writing skills

Related Conditions & MeSH terms

• Rehabilitation
• Schizophrenia

Intervention

Behavioral:
• lifestyle redesign program
In this group, it starts with health education, the participants then change their opinions and experience health activities, and it ends with discussion and sharing their experience.

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Taoyuan Psychiatric Center, Ministry of Health and Welfare, Executive Yuan, R.O.C. Taiwan

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change scores of Brief Psychiatric Symptom Rating Scale (BSRS)	The Chinese version of BSRS with 50 items is administered to measure psychiatric symptoms. BSRS items were evaluated on a five-point Likert scale from 0 (not present) to 4 (extremely severe). The total score ranged from 0 to 200, with higher scores reflecting more severe of psychiatric symptoms.	3 times: 1 to 2 weeks before intervention, 1 to 5 days after intervention and at 1 month after intervention
Primary	Change scores of Occupational Self Assessment (OSA)	The OSA with 29 items is administered to measure occupational engagement.	3 times: 1 to 2 weeks before intervention, 1 to 5 days after intervention and at 1 month after intervention
Primary	Change scores of Schizophrenia Quality of Life Scale Revision 4 (SQLS-R4)	The Chinese version of Schizophrenia Quality of Life Scale Revision 4 (SQLS-R4) was administered to measure subjective quality of life. The total scores ranged from 33-165, with higher scores indicating comparatively lower quality of life.	3 times: 1 to 2 weeks before intervention, 1 to 5 days after intervention and at 1 month after intervention
Primary	Change scores of Montreal Cognitive Assessment (MoCA)	The Chinese version of MoCA was administered to measure cognition, with higher scores indicating better cognition.	3 times: 1 to 2 weeks before intervention, 1 to 5 days after intervention and at 1 month after intervention